000 | 01921 a2200517 4500 | ||
---|---|---|---|
005 | 20250517142740.0 | ||
264 | 0 | _c20180309 | |
008 | 201803s 0 0 eng d | ||
022 | _a1555-8576 | ||
024 | 7 |
_a10.1080/15384047.2017.1294293 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Jing-Wen | |
245 | 0 | 0 |
_aSequential development of peripheral t-cell lymphoma post immunochemotherapy of diffuse large B cell lymphoma. _h[electronic resource] |
260 |
_bCancer biology & therapy _c04 2017 |
||
300 |
_a201-202 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
650 | 0 | 4 |
_aCytarabine _xtherapeutic use |
650 | 0 | 4 |
_aEpstein-Barr Virus Infections _xdiagnosis |
650 | 0 | 4 |
_aEtoposide _xtherapeutic use |
650 | 0 | 4 | _aGene Rearrangement |
650 | 0 | 4 |
_aGenes, Immunoglobulin Heavy Chain _xgenetics |
650 | 0 | 4 |
_aHerpesvirus 4, Human _xisolation & purification |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aLymph Nodes _xpathology |
650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xgenetics |
650 | 0 | 4 |
_aLymphoma, T-Cell, Peripheral _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNeoplasms, Second Primary |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xgenetics |
650 | 0 | 4 |
_aRituximab _xtherapeutic use |
650 | 0 | 4 | _aTomography, X-Ray Computed |
650 | 0 | 4 |
_aTongue _xpathology |
700 | 1 | _aChen, Jia-Yan | |
700 | 1 | _aLu, Chen | |
700 | 1 | _aTang, Xi | |
773 | 0 |
_tCancer biology & therapy _gvol. 18 _gno. 4 _gp. 201-202 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/15384047.2017.1294293 _zAvailable from publisher's website |
999 |
_c26953551 _d26953551 |